Viking Therapeutics to Present Data From Phase 2b VOYAGE Study of VK2809 in Patients With Biopsy-Confirmed NASH/MASH at the 75th Liver Meeting 2024

PR Newswire16:05 ET

Is Viking Therapeutics a Buy on the Dip?

Yahoo FinanceNov 10 05:15 ET

4 Reasons Why Buying Viking Therapeutics Stock Right Now Is a Smart Move

Yahoo FinanceNov 8 07:10 ET

Peace Medical Acquired by Experienced Healthcare Professional, Ensuring Continuity and Growth

PR NewswireNov 7 15:10 ET

Got $5,000? Viking Therapeutics Stock Just Got a Big New Green Flag

Yahoo FinanceNov 7 10:15 ET

Viking Therapeutics (VKTX) Stock Surges on Promising Treatment Pipeline

TipRanksNov 6 03:29 ET